Transforming ovarian cancer care by targeting minimal residual disease

Amir A. Jazaeri; Rachel Grisham; Anne Knisely; Stefani Spranger; Dmitriy Zamarin; R. Tyler Hillman; Barrett C. Lawson; Kathleen H. Burns; Sanghoon Lee; Shannon N. Westin; Enrico Moiso; Marc J. Williams; Neelkanth M. Bardhan; Thomas Pisanic; Ursula Matulonis; Britta Weigelt; Ie Ming Shih; Panagiotis A. Konstantinopoulos; Stephanie Gaillard; Linghua Wang; Carol Aghajanian; Alan D. D'Andrea; Paula Hammond; Sohrab Shah; Kai W. Wucherpfennig; Karen H. Lu

doi:10.1016/j.medj.2023.08.004

Transforming ovarian cancer care by targeting minimal residual disease

Amir A. Jazaeri, Rachel Grisham, Anne Knisely, Stefani Spranger, Dmitriy Zamarin, R. Tyler Hillman, Barrett C. Lawson, Kathleen H. Burns, Sanghoon Lee, Shannon N. Westin, Enrico Moiso, Marc J. Williams, Neelkanth M. Bardhan, Thomas Pisanic, Ursula Matulonis, Britta Weigelt, Ie Ming Shih, Panagiotis A. Konstantinopoulos, Stephanie Gaillard, Linghua WangCarol Aghajanian, Alan D. D'Andrea, Paula Hammond, Sohrab Shah, Kai W. Wucherpfennig, Karen H. Lu

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.

Original language	English
Pages (from-to)	755-760
Number of pages	6
Journal	Med
Volume	4
Issue number	11
DOIs	https://doi.org/10.1016/j.medj.2023.08.004
State	Published - 10 Nov 2023
Externally published	Yes

Access to Document

10.1016/j.medj.2023.08.004

Cite this

Jazaeri, A. A., Grisham, R., Knisely, A., Spranger, S., Zamarin, D., Hillman, R. T., Lawson, B. C., Burns, K. H., Lee, S., Westin, S. N., Moiso, E., Williams, M. J., Bardhan, N. M., Pisanic, T., Matulonis, U., Weigelt, B., Shih, I. M., Konstantinopoulos, P. A., Gaillard, S., ... Lu, K. H. (2023). Transforming ovarian cancer care by targeting minimal residual disease. Med, 4(11), 755-760. https://doi.org/10.1016/j.medj.2023.08.004

@article{87ba8c2f2e464dddb42248c522025374,

title = "Transforming ovarian cancer care by targeting minimal residual disease",

abstract = "Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.",

author = "Jazaeri, {Amir A.} and Rachel Grisham and Anne Knisely and Stefani Spranger and Dmitriy Zamarin and Hillman, {R. Tyler} and Lawson, {Barrett C.} and Burns, {Kathleen H.} and Sanghoon Lee and Westin, {Shannon N.} and Enrico Moiso and Williams, {Marc J.} and Bardhan, {Neelkanth M.} and Thomas Pisanic and Ursula Matulonis and Britta Weigelt and Shih, {Ie Ming} and Konstantinopoulos, {Panagiotis A.} and Stephanie Gaillard and Linghua Wang and Carol Aghajanian and D'Andrea, {Alan D.} and Paula Hammond and Sohrab Shah and Wucherpfennig, {Kai W.} and Lu, {Karen H.}",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Inc.",

year = "2023",

month = nov,

day = "10",

doi = "10.1016/j.medj.2023.08.004",

language = "English",

volume = "4",

pages = "755--760",

journal = "Med",

issn = "2666-6359",

publisher = "Cell Press",

number = "11",

}

Jazaeri, AA, Grisham, R, Knisely, A, Spranger, S, Zamarin, D, Hillman, RT, Lawson, BC, Burns, KH, Lee, S, Westin, SN, Moiso, E, Williams, MJ, Bardhan, NM, Pisanic, T, Matulonis, U, Weigelt, B, Shih, IM, Konstantinopoulos, PA, Gaillard, S, Wang, L, Aghajanian, C, D'Andrea, AD, Hammond, P, Shah, S, Wucherpfennig, KW & Lu, KH 2023, 'Transforming ovarian cancer care by targeting minimal residual disease', Med, vol. 4, no. 11, pp. 755-760. https://doi.org/10.1016/j.medj.2023.08.004

TY - JOUR

T1 - Transforming ovarian cancer care by targeting minimal residual disease

AU - Jazaeri, Amir A.

AU - Grisham, Rachel

AU - Knisely, Anne

AU - Spranger, Stefani

AU - Zamarin, Dmitriy

AU - Hillman, R. Tyler

AU - Lawson, Barrett C.

AU - Burns, Kathleen H.

AU - Lee, Sanghoon

AU - Westin, Shannon N.

AU - Moiso, Enrico

AU - Williams, Marc J.

AU - Bardhan, Neelkanth M.

AU - Pisanic, Thomas

AU - Matulonis, Ursula

AU - Weigelt, Britta

AU - Shih, Ie Ming

AU - Konstantinopoulos, Panagiotis A.

AU - Gaillard, Stephanie

AU - Wang, Linghua

AU - Aghajanian, Carol

AU - D'Andrea, Alan D.

AU - Hammond, Paula

AU - Shah, Sohrab

AU - Wucherpfennig, Kai W.

AU - Lu, Karen H.

PY - 2023/11/10

Y1 - 2023/11/10

N2 - Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.

AB - Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.

UR - http://www.scopus.com/inward/record.url?scp=85176990623&partnerID=8YFLogxK

U2 - 10.1016/j.medj.2023.08.004

DO - 10.1016/j.medj.2023.08.004

M3 - Comment/debate

C2 - 37951209

AN - SCOPUS:85176990623

SN - 2666-6359

VL - 4

SP - 755

EP - 760

JO - Med

JF - Med

IS - 11

ER -

Transforming ovarian cancer care by targeting minimal residual disease

Abstract

Access to Document

Fingerprint

Cite this